doi	title	authors	title_name	year	downloads	visitors	countries
10.1124/pr.114.009639	Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases	S. Siebert, A. Tsoukas, J. Robertson, I. McInnes	Pharmacological Reviews	2015	44	41	21
10.1124/pr.114.009456	Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy	S. Anguille, E. L. Smits, C. Bryant, H. H. Van Acker, H. Goossens, E. Lion, P. D. Fromm, V. F. Van Tendeloo, Z. N. Berneman	Pharmacological Reviews	2015	49	38	19
10.1124/jpet.114.222505	Targeting IL-33 in Autoimmunity and Inflammation	T. C. Theoharides, A. I. Petra, A. Taracanova, S. Panagiotidou, P. Conti	Journal of Pharmacology and Experimental Therapeutics	2015	29	23	13
10.1124/jpet.115.227298	Fibromyalgia Syndrome in Need of Effective Treatments	T. C. Theoharides, I. Tsilioni, L. Arbetman, S. Panagiotidou, J. M. Stewart, R. M. Gleason, I. J. Russell	Journal of Pharmacology and Experimental Therapeutics	2015	27	23	12
10.1124/dmd.114.061622	Mechanism-Based Inhibitory and Peroxisome Proliferator-Activated Receptor  -Dependent Modulating Effects of Silybin on Principal Hepatic Drug-Metabolizing Enzymes	H. Wang, T. Yan, Y. Xie, M. Zhao, Y. Che, J. Zhang, H. Liu, L. Cao, X. Cheng, Y. Xie, F. Li, Q. Qi, G. Wang, H. Hao	Drug Metabolism and Disposition	2015	36	22	5
10.1124/pr.114.009423	Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice	M. Schedlowski, P. Enck, W. Rief, U. Bingel	Pharmacological Reviews	2015	29	22	18
10.1124/pr.114.010215	The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy	J. R. van Beijnum, P. Nowak-Sliwinska, E. J. M. Huijbers, V. L. Thijssen, A. W. Griffioen	Pharmacological Reviews	2015	23	22	14
10.1124/pr.115.010629	Amylin: Pharmacology, Physiology, and Clinical Potential	D. L. Hay, S. Chen, T. A. Lutz, D. G. Parkes, J. D. Roth	Pharmacological Reviews	2015	22	22	14
10.1124/dmd.115.063826	Microbiome Disturbances and Autism Spectrum Disorders	C. S. Rosenfeld	Drug Metabolism and Disposition	2015	24	21	10
10.1124/dmd.114.062745	Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft	T. J. Raub, G. N. Wishart, P. Kulanthaivel, B. A. Staton, R. T. Ajamie, G. A. Sawada, L. M. Gelbert, H. E. Shannon, C. Sanchez-Martinez, A. De Dios	Drug Metabolism and Disposition	2015	28	20	9
10.1124/pr.113.008367	Novel Delivery Systems for Improving the Clinical Use of Peptides	M. Kovalainen, J. Monkare, J. Riikonen, U. Pesonen, M. Vlasova, J. Salonen, V.-P. Lehto, K. Jarvinen, K.-H. Herzig	Pharmacological Reviews	2015	19	18	9
10.1124/dmd.115.063800	Ginsenosides Regulate PXR/NF- B Signaling and Attenuate Dextran Sulfate Sodium-Induced Colitis	J. Zhang, L. Cao, H. Wang, X. Cheng, L. Wang, L. Zhu, T. Yan, Y. Xie, Y. Wu, M. Zhao, S. Ma, M. Wu, G. Wang, H. Hao	Drug Metabolism and Disposition	2015	29	17	2
10.1124/mol.114.095711	Nucleotides Acting at P2Y Receptors: Connecting Structure and Function	K. A. Jacobson, S. Paoletta, V. Katritch, B. Wu, Z.-G. Gao, Q. Zhao, R. C. Stevens, E. Kiselev	Molecular Pharmacology	2015	21	16	7
10.1124/pr.113.008201	Bile Acid Signaling in Metabolic Disease and Drug Therapy	T. Li, J. Y. L. Chiang	Pharmacological Reviews	2014	16	16	10
10.1124/pr.114.009381	The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis	R. S. Knipe, A. M. Tager, J. K. Liao	Pharmacological Reviews	2014	15	15	6
10.1124/pr.115.010512	Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders	A. F. T. Arnsten, M. Wang, C. D. Paspalas	Pharmacological Reviews	2015	16	15	9
10.1124/dmd.115.065920	Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification	J. E. Sager, J. Yu, I. Ragueneau-Majlessi, N. Isoherranen	Drug Metabolism and Disposition	2015	23	14	8
10.1124/jpet.114.222372	High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor- 1/Smad2/3 Signaling	L.-C. Li, D.-L. Li, L. Xu, X.-T. Mo, W.-H. Cui, P. Zhao, W.-C. Zhou, J. Gao, J. Li	Journal of Pharmacology and Experimental Therapeutics	2015	17	14	3
10.1124/jpet.115.225391	Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model	M. Nakajima, S. Nagase, M. Iida, S. Takeda, M. Yamashita, A. Watari, Y. Shirasago, M. Fukasawa, H. Takeda, T. Sawasaki, K. Yagi, M. Kondoh	Journal of Pharmacology and Experimental Therapeutics	2015	15	14	7
10.1124/jpet.115.225680	CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine	M. Klieber, H. Oberacher, S. Hofstaetter, B. Beer, M. Neururer, A. Amann, H. Alber, A. Modak	Journal of Pharmacology and Experimental Therapeutics	2015	15	14	6
10.1124/mol.114.096701	Rapid Throughput Analysis Demonstrates that Chemicals with Distinct Seizurogenic Mechanisms Differentially Alter Ca2+ Dynamics in Networks Formed by Hippocampal Neurons in Culture	Z. Cao, X. Zou, Y. Cui, S. Hulsizer, P. J. Lein, H. Wulff, I. N. Pessah	Molecular Pharmacology	2015	18	14	5
10.1124/mol.114.097659	Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels	W. A. Catterall, T. M. Swanson	Molecular Pharmacology	2015	16	14	9
10.1124/mol.115.098616	Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells	Y. R. Jung, E. J. Kim, H. J. Choi, J.-J. Park, H.-S. Kim, Y.-J. Lee, M.-J. Park, M. Lee	Molecular Pharmacology	2015	14	14	7
10.1124/mol.115.099325	Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics	M. E. Law, P. E. Corsino, S. Narayan, B. K. Law	Molecular Pharmacology	2015	18	14	8
10.1124/pr.114.009001	The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology	C. Esser, A. Rannug	Pharmacological Reviews	2015	16	14	6
10.1124/dmd.115.064949	Human Liver Cytochrome P450 Enzymes and Microsomal Thiol Methyltransferase Are Involved in the Stereoselective Formation and Methylation of the Pharmacologically Active Metabolite of Clopidogrel	C. Liu, Z. Chen, K. Zhong, L. Li, W. Zhu, X. Chen, D. Zhong	Drug Metabolism and Disposition	2015	13	13	3
10.1124/jpet.115.223107	A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor   with Excellent Effect on Insulin Resistance and Type 2 Diabetes	H.-j. Liu, C.-y. Zhang, F. Song, T. Xiao, J. Meng, Q. Zhang, C.-l. Liang, S. Li, J. Wang, B. Zhang, Y.-r. Liu, T. Sun, H.-g. Zhou	Journal of Pharmacology and Experimental Therapeutics	2015	13	13	8
10.1124/mol.114.095414	In Silico Screening for Inhibitors of P-Glycoprotein That Target the Nucleotide Binding Domains	F. K. Brewer, C. A. Follit, P. D. Vogel, J. G. Wise	Molecular Pharmacology	2014	14	13	3
10.1124/mol.114.096735	Circadian Modulation in the Intestinal Absorption of P-Glycoprotein Substrates in Monkeys	M. Iwasaki, S. Koyanagi, N. Suzuki, C. Katamune, N. Matsunaga, N. Watanabe, M. Takahashi, T. Izumi, S. Ohdo	Molecular Pharmacology	2015	16	13	2
10.1124/mol.115.098178	Identification and Characterization of ProTx-III [ -TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens	F. C. Cardoso, Z. Dekan, K. J. Rosengren, A. Erickson, I. Vetter, J. R. Deuis, V. Herzig, P. F. Alewood, G. F. King, R. J. Lewis	Molecular Pharmacology	2015	14	13	4
10.1124/mol.115.099457	Protein Kinase C (PKC)  Pseudosubstrate Inhibitor Peptide Promiscuously Binds PKC Family Isoforms and Disrupts Conventional PKC Targeting and Translocation	A. S. Bogard, S. J. Tavalin	Molecular Pharmacology	2015	14	13	5
10.1124/jpet.114.222448	Trapping Poly(ADP-Ribose) Polymerase	Y. Shen, M. Aoyagi-Scharber, B. Wang	Journal of Pharmacology and Experimental Therapeutics	2015	15	12	6
10.1124/jpet.115.223289	Arsenic, Reactive Oxygen, and Endothelial Dysfunction	D. C. Ellinsworth	Journal of Pharmacology and Experimental Therapeutics	2015	12	12	7
10.1124/jpet.115.225508	Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents	T. Oguma, K. Nakayama, C. Kuriyama, Y. Matsushita, K. Yoshida, K. Hikida, N. Obokata, M. Tsuda-Tsukimoto, A. Saito, K. Arakawa, K. Ueta, M. Shiotani	Journal of Pharmacology and Experimental Therapeutics	2015	12	12	10
10.1124/mol.114.096008	G Protein Regulation of Neuronal Calcium Channels: Back to the Future	J. Proft, N. Weiss	Molecular Pharmacology	2014	20	12	8
10.1124/mol.115.098400	Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor	J. L. Miller, T. J. Church, D. Leonoudakis, K. Lariosa-Willingham, N. L. Frigon, C. S. Tettenborn, J. R. Spencer, J. Punnonen	Molecular Pharmacology	2015	13	12	3
10.1124/dmd.114.062836	GW4064, an Agonist of Farnesoid X Receptor, Represses CYP3A4 Expression in Human Hepatocytes by Inducing Small Heterodimer Partner Expression	S. Zhang, X. Pan, H. Jeong	Drug Metabolism and Disposition	2015	15	11	4
10.1124/dmd.115.064121	Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury	X. Li, K. Zhong, Z. Guo, D. Zhong, X. Chen	Drug Metabolism and Disposition	2015	13	11	3
10.1124/dmd.115.065698	Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids	C. D. Klaassen, J. Y. Cui	Drug Metabolism and Disposition	2015	14	11	7
10.1124/dmd.115.065813	In Vitro and In Vivo Characterization of Reactive Intermediates of Corynoline	X. Mao, Y. Peng, J. Zheng	Drug Metabolism and Disposition	2015	14	11	1
10.1124/mol.114.095554	Antiproliferation Activity of a Small Molecule Repressor of Liver Receptor Homolog 1	C. A. Corzo, Y. Mari, M. R. Chang, T. Khan, D. Kuruvilla, P. Nuhant, N. Kumar, G. M. West, D. R. Duckett, W. R. Roush, P. R. Griffin	Molecular Pharmacology	2014	14	11	5
10.1124/mol.115.098376	Preclinical Evaluation of DMA, a Bisbenzimidazole, as Radioprotector: Toxicity, Pharmacokinetics, and Biodistribution Studies in Balb/c Mice	H. Nimesh, V. Tiwari, C. Yang, S. R. Gundala, K. Chuttani, P. P. Hazari, A. K. Mishra, A. Sharma, J. Lal, A. Katyal, R. Aneja, V. Tandon	Molecular Pharmacology	2015	11	11	5
10.1124/mol.115.099663	A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography	C. L. Piscitelli, J. Kean, C. de Graaf, X. Deupi	Molecular Pharmacology	2015	12	11	9
10.1124/pr.114.010454	Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli	S. S. Karnik, H. Unal, J. R. Kemp, K. C. Tirupula, S. Eguchi, P. M. L. Vanderheyden, W. G. Thomas	Pharmacological Reviews	2015	12	11	8
10.1124/dmd.114.061473	Systemic Exposure to and Disposition of Catechols Derived from Salvia miltiorrhiza Roots (Danshen) after Intravenous Dosing DanHong Injection in Human Subjects, Rats, and Dogs	M. Li, F. Wang, Y. Huang, F. Du, C. Zhong, O. E. Olaleye, W. Jia, Y. Li, F. Xu, J. Dong, J. Li, J. B. R. Lim, B. Zhao, L. Jia, L. Li, C. Li	Drug Metabolism and Disposition	2015	16	10	2
10.1124/dmd.114.062596	Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics	N. Djebli, D. Fabre, X. Boulenc, G. Fabre, E. Sultan, F. Hurbin	Drug Metabolism and Disposition	2015	10	10	2
10.1124/dmd.115.064345	Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner	E. Lee, Z. Wu, J. C. Shon, K.-H. Liu	Drug Metabolism and Disposition	2015	11	10	2
10.1124/jpet.114.220558	CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration--In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window	G. Villetti, C. Carnini, L. Battipaglia, L. Preynat, P. T. Bolzoni, F. Bassani, P. Caruso, M. Bergamaschi, A. R. Pisano, V. Puviani, F. F. Stellari, V. Cenacchi, R. Volta, V. Bertacche, V. Mileo, V. Bagnacani, E. Moretti, P. Puccini, S. Catinella, F. Facchinetti, A. Sala, M. Civelli	Journal of Pharmacology and Experimental Therapeutics	2015	10	10	4
10.1124/jpet.114.221150	Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia	D. Rudolph, M. A. Impagnatiello, C. Blaukopf, C. Sommer, D. W. Gerlich, M. Roth, U. Tontsch-Grunt, A. Wernitznig, F. Savarese, M. H. Hofmann, C. Albrecht, L. Geiselmann, M. Reschke, P. Garin-Chesa, J. Zuber, J. Moll, G. R. Adolf, N. Kraut	Journal of Pharmacology and Experimental Therapeutics	2015	12	10	5
10.1124/jpet.114.221796	The Ellagic Acid Derivative 4,4'-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16	A. Ramirez de Molina, T. Vargas, S. Molina, J. Sanchez, J. Martinez-Romero, M. Gonzalez-Vallinas, R. Martin-Hernandez, R. Sanchez-Martinez, M. Gomez de Cedron, A. Davalos, L. Calani, D. Del Rio, A. Gonzalez-Sarrias, J. C. Espin, F. A. Tomas-Barberan, G. Reglero	Journal of Pharmacology and Experimental Therapeutics	2015	10	10	5
10.1124/jpet.115.223305	Viral and Other Cell-Penetrating Peptides as Vectors of Therapeutic Agents in Medicine	J. Durzy ska, ucja Przysiecka, R. Nawrot, J. Barylski, G. Nowicki, A. Warowicka, O. Musidlak, A. Go dzicka-Jozefiak	Journal of Pharmacology and Experimental Therapeutics	2015	10	10	6
10.1124/mol.114.095810	Adenosine Monophosphate-Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation	S. Krishan, D. R. Richardson, S. Sahni	Molecular Pharmacology	2014	10	10	6
10.1124/mol.114.096776	Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to Metformin	E. C. Chen, X. Liang, S. W. Yee, E. G. Geier, S. L. Stocker, L. Chen, K. M. Giacomini	Molecular Pharmacology	2015	10	10	5
10.1124/mol.115.097998	Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases	H. Yuan, C.-M. Low, O. A. Moody, A. Jenkins, S. F. Traynelis	Molecular Pharmacology	2015	14	10	7
10.1124/dmd.114.062000	Renal Tubular Secretion of Tanshinol: Molecular Mechanisms, Impact on Its Systemic Exposure, and Propensity for Dose-Related Nephrotoxicity and for Renal Herb-Drug Interactions	W. Jia, F. Du, X. Liu, R. Jiang, F. Xu, J. Yang, L. Li, F. Wang, O. E. Olaleye, J. Dong, C. Li	Drug Metabolism and Disposition	2015	9	9	5
10.1124/dmd.115.064253	Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker	B. M. Rock, M. E. Tometsko, S. K. Patel, K. J. Hamblett, W. C. Fanslow, D. A. Rock	Drug Metabolism and Disposition	2015	14	9	4
10.1124/dmd.115.064881	Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration	C. Liu, M. Hu, H. Guo, M. Zhang, J. Zhang, F. Li, Z. Zhong, Y. Chen, Y. Li, P. Xu, J. Li, L. Liu, X. Liu	Drug Metabolism and Disposition	2015	10	9	3
10.1124/dmd.115.065086	Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction	B. T. Gufford, G. Chen, A. G. Vergara, P. Lazarus, N. H. Oberlies, M. F. Paine	Drug Metabolism and Disposition	2015	9	9	5
10.1124/dmd.115.065623	P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms	M. G. McDonald, N. T. Au, A. E. Rettie	Drug Metabolism and Disposition	2015	13	9	7
10.1124/dmd.115.065664	Single-Nucleotide Polymorphisms in Cytochrome P450 2E1 (CYP2E1) 3'-Untranslated Region Affect the Regulation of CYP2E1 by miR-570	M. Nakano, T. Mohri, T. Fukami, M. Takamiya, Y. Aoki, H. L. McLeod, M. Nakajima	Drug Metabolism and Disposition	2015	9	9	4
10.1124/jpet.114.217968	Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway	L. Ding, J. Li, B. Song, X. Xiao, W. Huang, B. Zhang, X. Tang, M. Qi, Q. Yang, Q. Yang, L. Yang, Z. Wang	Journal of Pharmacology and Experimental Therapeutics	2014	11	9	3
10.1124/jpet.115.225540	Control of Macrophage Dynamics as a Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation	W. Ohashi, K. Hattori, Y. Hattori	Journal of Pharmacology and Experimental Therapeutics	2015	11	9	4
10.1124/jpet.115.225656	The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4	J. Wen, J. Luo, W. Huang, J. Tang, H. Zhou, W. Zhang	Journal of Pharmacology and Experimental Therapeutics	2015	10	9	6
10.1124/jpet.115.226043	Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury	L. H. Pojoga, T. M. Yao, L. A. Opsasnick, W. T. Siddiqui, O. M. Reslan, G. K. Adler, G. H. Williams, R. A. Khalil	Journal of Pharmacology and Experimental Therapeutics	2015	9	9	7
10.1124/mol.113.091249	Molecular Basis for Selective Serotonin Reuptake Inhibition by the Antidepressant Agent Fluoxetine (Prozac)	J. Andersen, N. Stuhr-Hansen, L. G. Zachariassen, H. Koldso, B. Schiott, K. Stromgaard, A. S. Kristensen	Molecular Pharmacology	2014	9	9	4
10.1124/mol.114.096065	The c-MET/PI3K Signaling Is Associated with Cancer Resistance to Doxorubicin and Photodynamic Therapy by Elevating BCRP/ABCG2 Expression	K.-A. Jung, B.-h. Choi, M.-K. Kwak	Molecular Pharmacology	2014	14	9	2
10.1124/mol.114.096743	Exposure to Diethylstilbestrol during Pregnancy Modulates MicroRNA Expression Profile in Mothers and Fetuses Reflecting Oncogenic and Immunological Changes	N. P. Singh, I. K. Abbas, M. Menard, U. P. Singh, J. Zhang, P. Nagarkatti, M. Nagarkatti	Molecular Pharmacology	2015	10	9	4
10.1124/mol.114.097022	Detection of New Biased Agonists for the Serotonin 5-HT2A Receptor: Modeling and Experimental Validation	M. Marti-Solano, A. Iglesias, G. de Fabritiis, F. Sanz, J. Brea, M. I. Loza, M. Pastor, J. Selent	Molecular Pharmacology	2015	12	9	5
10.1124/mol.114.097204	Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I-Mutant Fibroblasts	R. Felici, A. Lapucci, L. Cavone, S. Pratesi, R. Berlinguer-Palmini, A. Chiarugi	Molecular Pharmacology	2015	10	9	3
10.1124/pr.111.005116	Antitussive Drugs--Past, Present, and Future	P. V. Dicpinigaitis, A. H. Morice, S. S. Birring, L. McGarvey, J. A. Smith, B. J. Canning, C. P. Page	Pharmacological Reviews	2014	9	9	6
10.1124/pr.112.006536	Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity	R. Lang, A. L. Gundlach, F. E. Holmes, S. A. Hobson, D. Wynick, T. Hokfelt, B. Kofler	Pharmacological Reviews	2014	10	9	6
10.1124/dmd.114.057216	Zinc Finger Nuclease-Mediated Gene Knockout Results in Loss of Transport Activity for P-Glycoprotein, BCRP, and MRP2 in Caco-2 Cells	K. E. Sampson, A. Brinker, J. Pratt, N. Venkatraman, Y. Xiao, J. Blasberg, T. Steiner, M. Bourner, D. C. Thompson	Drug Metabolism and Disposition	2014	29	8	1
10.1124/dmd.114.059261	Cytochrome P450-Mediated Metabolic Activation of Diosbulbin B	D. Lin, C. Li, Y. Peng, H. Gao, J. Zheng	Drug Metabolism and Disposition	2014	9	8	2
10.1124/dmd.114.059923	The Hepatobiliary Disposition of Timosaponin B2 Is Highly Dependent on Influx/Efflux Transporters but Not Metabolism	J. Sheng, X. Tian, G. Xu, Z. Wu, C. Chen, L. Wang, L. Pan, C. Huang, G. Pan	Drug Metabolism and Disposition	2014	8	8	2
10.1124/dmd.114.061416	Mass Spectrometric Evaluation of Mephedrone In Vivo Human Metabolism: Identification of Phase I and Phase II Metabolites, Including a Novel Succinyl Conjugate	O. J. Pozo, M. Ibanez, J. V. Sancho, J. Lahoz-Beneytez, M. Farre, E. Papaseit, R. de la Torre, F. Hernandez	Drug Metabolism and Disposition	2014	8	8	6
10.1124/dmd.115.063552	UDP-Glucuronosyltransferases 1A6 and 1A9 are the Major Isozymes Responsible for the 7-O-Glucuronidation of Esculetin and 4-Methylesculetin in Human Liver Microsomes	L. Zhu, L. Lu, S. Zeng, F. Luo, P. Dai, P. Wu, Y. Wang, L. Liu, M. Hu, Z. Liu	Drug Metabolism and Disposition	2015	9	8	3
10.1124/dmd.115.065870	Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions	A. Pattanawongsa, N. Chau, A. Rowland, J. O. Miners	Drug Metabolism and Disposition	2015	8	8	4
10.1124/jpet.114.216820	The G Protein-Biased  -Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo	K. L. White, J. E. Robinson, H. Zhu, J. F. DiBerto, P. R. Polepally, J. K. Zjawiony, D. E. Nichols, C. J. Malanga, B. L. Roth	Journal of Pharmacology and Experimental Therapeutics	2014	9	8	2
10.1124/jpet.114.220350	Four Cation-Selective Transporters Contribute to Apical Uptake and Accumulation of Metformin in Caco-2 Cell Monolayers	T. Han, W. R. Proctor, C. L. Costales, H. Cai, R. S. Everett, D. R. Thakker	Journal of Pharmacology and Experimental Therapeutics	2015	9	8	1
10.1124/jpet.114.221952	Pilocarpine-Induced Convulsive Activity Is Limited by Multidrug Transporters at the Rodent Blood-Brain Barrier	K. Romermann, J. P. Bankstahl, W. Loscher, M. Bankstahl	Journal of Pharmacology and Experimental Therapeutics	2015	9	8	5
10.1124/jpet.115.225326	AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing  9-Tetrahydrocannabinol-Like Effects in Mice	J. L. Wiley, J. A. Marusich, T. W. Lefever, K. R. Antonazzo, M. T. Wallgren, R. A. Cortes, P. R. Patel, M. Grabenauer, K. N. Moore, B. F. Thomas	Journal of Pharmacology and Experimental Therapeutics	2015	9	8	4
10.1124/jpet.115.227959	Recruitment of  -Arrestin 1 and 2 to the  2-Adrenoceptor: Analysis of 65 Ligands	T. Littmann, M. Gottle, M. T. Reinartz, S. Kalble, I. W. Wainer, T. Ozawa, R. Seifert	Journal of Pharmacology and Experimental Therapeutics	2015	14	8	3
10.1124/mol.114.095588	An Integrated Biological Approach to Guide the Development of Metal-Chelating Inhibitors of Influenza Virus PA Endonuclease	A. Stevaert, S. Nurra, N. Pala, M. Carcelli, D. Rogolino, C. Shepard, R. A. Domaoal, B. Kim, M. Alfonso-Prieto, S. A. E. Marras, M. Sechi, L. Naesens	Molecular Pharmacology	2014	8	8	5
10.1124/mol.114.096495	Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation	T. H. Smith, L. C. Blume, A. Straiker, J. O. Cox, B. G. David, J. R. S. McVoy, K. W. Sayers, J. L. Poklis, R. A. Abdullah, M. Egertova, C.-K. Chen, K. Mackie, M. R. Elphick, A. C. Howlett, D. E. Selley	Molecular Pharmacology	2015	8	8	2
10.1124/mol.114.096982	Staurosporine Induces Formation of Two Types of Extra-Long Cell Protrusions: Actin-Based Filaments and Microtubule-Based Shafts	T. Kohno, T. Ninomiya, S. Kikuchi, T. Konno, T. Kojima	Molecular Pharmacology	2015	8	8	2
10.1124/mol.114.097345	Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice	S. Morooka, M. Hoshina, I. Kii, T. Okabe, H. Kojima, N. Inoue, Y. Okuno, M. Denawa, S. Yoshida, J. Fukuhara, K. Ninomiya, T. Ikura, T. Furuya, T. Nagano, K. Noda, S. Ishida, T. Hosoya, N. Ito, N. Yoshimura, M. Hagiwara	Molecular Pharmacology	2015	8	8	6
10.1124/mol.115.098848	Biased Agonism of Endogenous Opioid Peptides at the  -Opioid Receptor	G. L. Thompson, J. R. Lane, T. Coudrat, P. M. Sexton, A. Christopoulos, M. Canals	Molecular Pharmacology	2015	9	8	4
10.1124/mol.115.099143	Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity	D. E. Durrant, A. Das, S. Dyer, S. Tavallai, P. Dent, R. C. Kukreja	Molecular Pharmacology	2015	9	8	2
10.1124/mol.115.099192	Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor	E. Khajehali, D. T. Malone, M. Glass, P. M. Sexton, A. Christopoulos, K. Leach	Molecular Pharmacology	2015	10	8	7
10.1124/mol.115.099630	"Fulfilling the Promise of ""Biased"" G Protein-Coupled Receptor Agonism"	L. M. Luttrell, S. Maudsley, L. M. Bohn	Molecular Pharmacology	2015	9	8	6
10.1124/dmd.113.055962	Hepatic Glucuronidation of Isoneochamaejasmin A from the Traditional Chinese Medicine Stellera Chamaejasme L. Root	L. Yu, J. Pu, M. Zuo, X. Zhang, Y. Cao, S. Chen, Y. Lou, Q. Zhou, H. Hu, H. Jiang, J. Chen, S. Zeng	Drug Metabolism and Disposition	2014	7	7	1
10.1124/dmd.114.058917	Toward Sensitive and Accurate Analysis of Antibody Biotherapeutics by Liquid Chromatography Coupled with Mass Spectrometry	B. An, M. Zhang, J. Qu	Drug Metabolism and Disposition	2014	7	7	1
10.1124/dmd.114.059410	Hydrastine Pharmacokinetics and Metabolism after a Single Oral Dose of Goldenseal (Hydrastis canadensis) to Humans	P. K. Gupta, G. Barone, B. J. Gurley, E. K. Fifer, H. P. Hendrickson	Drug Metabolism and Disposition	2015	9	7	5
10.1124/dmd.114.062299	Short-Term Fasting Alters Cytochrome P450-Mediated Drug Metabolism in Humans	L. A. Lammers, R. Achterbergh, E. M. de Vries, F. S. van Nierop, H.-J. Klumpen, M. R. Soeters, A. Boelen, J. A. Romijn, R. A. A. Mathot	Drug Metabolism and Disposition	2015	9	7	4
10.1124/dmd.115.064170	Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2- Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration	H. Liu, N. Yu, S. Lu, S. Ito, X. Zhang, B. Prasad, E. He, X. Lu, Y. Li, F. Wang, H. Xu, G. An, J. D. Unadkat, H. Kusuhara, Y. Sugiyama, J. Sahi	Drug Metabolism and Disposition	2015	8	7	3
10.1124/dmd.115.065953	Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Controls Efflux Transport of Hesperetin Sulfates in Sulfotransferase 1A3-Overexpressing Human Embryonic Kidney 293 Cells	H. Sun, X. Wang, X. Zhou, D. Lu, Z. Ma, B. Wu	Drug Metabolism and Disposition	2015	8	7	5
10.1124/jpet.114.213793	Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator	K. Maeda, H. Sugino, H. Akazawa, N. Amada, J. Shimada, T. Futamura, H. Yamashita, N. Ito, R. D. McQuade, A. Mork, A. L. Pehrson, M. Hentzer, V. Nielsen, C. Bundgaard, J. Arnt, T. B. Stensbol, T. Kikuchi	Journal of Pharmacology and Experimental Therapeutics	2014	8	7	3
10.1124/jpet.114.220368	Protective Role of Cannabinoid Receptor 2 Activation in Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure through Regulation of Macrophage Polarization and MicroRNAs	S. Tomar, E. E. Zumbrun, M. Nagarkatti, P. S. Nagarkatti	Journal of Pharmacology and Experimental Therapeutics	2015	7	7	6
10.1124/jpet.114.221176	VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease	S. Mahajan, J. K. Hogan, D. Shlyakhter, L. Oh, F. G. Salituro, L. Farmer, T. C. Hoock	Journal of Pharmacology and Experimental Therapeutics	2015	9	7	4
10.1124/jpet.115.224246	Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity	P. R. Mangan, L. J. Su, V. Jenny, A. L. Tatum, C. Picarillo, S. Skala, N. Ditto, Z. Lin, X. Yang, P. Z. Cotter, D. J. Shuster, Y. Song, V. Borowski, R. L. Thomas, E. M. Heimrich, B. Devaux, R. Das Gupta, I. Carvajal, K. W. McIntyre, J. Xie, Q. Zhao, M. Struthers, L. M. Salter-Cid	Journal of Pharmacology and Experimental Therapeutics	2015	7	7	5
